Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Michael McKenna, MBChB
GSK, United Kingdom
Disclosure(s): GSK: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-575) Evaluation of Weight Gain on Incident Hypertension among People Living with HIV-1 Receiving Dolutegravir (DTG)-Based Regimens or Comparator Antiretroviral Therapy (cART) in Randomized Clinical Trials through 96 Weeks
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
